MGIA
CATX icon

Moneta Group Investment Advisors’s Perspective Therapeutics CATX Stock Holding History

Moneta Group Investment Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.8K Hold
23,707
– – ﹤0.01% 864
2026
Q1 		$98.9K Hold
23,707
– – ﹤0.01% 782
2025
Q4 		$65.2K Hold
23,707
– – ﹤0.01% 798
2025
Q3 		$81.3K Hold
23,707
– – ﹤0.01% 778
2025
Q2 		$81.6K Hold
23,707
– – ﹤0.01% 693
2025
Q1 		$50.5K Hold
23,707
– – ﹤0.01% 657
2024
Q4 		$75.6K Hold
23,707
– – ﹤0.01% 652
2024
Q3 		$316K Hold
23,707
– – ﹤0.01% 506
2024
Q2 		$236K Buy
23,707
+21,336
+900% +$308K ﹤0.01% 542
2024
Q1 		$282K Buy
+2,371
New +$20.2K ﹤0.01% 504

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Moneta Group Investment Advisors's CATX Position: Q2 2026 in Review

Moneta Group Investment Advisors held its Perspective Therapeutics (CATX) position steady in Q2 2026 at 23,707 shares worth $80.8K. The position accounts for ﹤0.01% of the portfolio, ranked #864.

Moneta Group Investment Advisors first reported a position in CATX in Q1 2024 and has held it in 10 quarters since. The position peaked at $316K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Moneta Group Investment Advisors held 23,707 shares of Perspective Therapeutics worth $80.8K as of Q2 2026.
  • Moneta Group Investment Advisors left its Perspective Therapeutics share count unchanged in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q2 2026, its #864 holding.
  • Moneta Group Investment Advisors first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Moneta Group Investment Advisors's Perspective Therapeutics position peaked at $316K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.